Follow the people · Insider
William Guyer
William Guyer files insider transactions with the SEC as a chief development officer of Corcept Therapeutics (CORT). We hold 10 disclosed purchases and sales filed since 3 September 2021, 3 of them in the last 90 days.
- Files forCORT
- Disclosed buys and sells10 in all, 3 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 September 2021 — 1 September 2026Chief Development Officer · Corcept Therapeutics (CORT)153 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- was granted 164 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- was granted 164 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 16,300 shares of Corcept TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 11,530 shares of Corcept TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 4,770 shares of Corcept TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 16,300 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option (right to buy) · traded 10 August 2026 · filed 12 August 2026
- exercised options over 3,700 shares of Corcept TherapeuticsSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 3,700 shares of Corcept TherapeuticsSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- exercised options over 3,700 shares of Corcept Therapeutics (a derivative holding)SEC Form 46 August 2026Stock Option (right to buy) · traded 4 August 2026 · filed 6 August 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- ▼ sold on the open market 19,048 shares of Corcept TherapeuticsSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- ▼ sold on the open market 952 shares of Corcept TherapeuticsSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 48 July 2026Stock Option (right to buy) · traded 7 July 2026 · filed 8 July 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 44 June 2026Common Stock · traded 2 June 2026 · filed 4 June 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 44 June 2026Common Stock · traded 2 June 2026 · filed 4 June 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 June 2026Stock Option (right to buy) · traded 2 June 2026 · filed 4 June 2026
- was granted 877 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- was granted 877 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 47 May 2026Common Stock · traded 5 May 2026 · filed 7 May 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 47 May 2026Common Stock · traded 5 May 2026 · filed 7 May 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 47 May 2026Stock Option (right to buy) · traded 5 May 2026 · filed 7 May 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 48 April 2026Stock Option (right to buy) · traded 7 April 2026 · filed 8 April 2026
- exercised options over 11,767 shares of Corcept TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 11,767 shares of Corcept TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- exercised options over 11,767 shares of Corcept Therapeutics (a derivative holding)SEC Form 424 March 2026Stock Option (right to buy) · traded 20 March 2026 · filed 24 March 2026
- exercised options over 11,767 shares of Corcept Therapeutics (a derivative holding)SEC Form 424 March 2026Stock Option (right to buy) · traded 20 March 2026 · filed 24 March 2026
- exercised options over 11,767 shares of Corcept TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 11,767 shares of Corcept TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- exercised options over 8,233 shares of Corcept TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 8,233 shares of Corcept TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 8,233 shares of Corcept Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (right to buy) · traded 4 March 2026 · filed 6 March 2026
- exercised options over 8,233 shares of Corcept Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (right to buy) · traded 4 March 2026 · filed 6 March 2026
- exercised options over 8,233 shares of Corcept TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 8,233 shares of Corcept TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 498 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 498 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 498 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 498 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 45 February 2026Stock option (right to buy) · traded 3 February 2026 · filed 5 February 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 45 February 2026Stock option (right to buy) · traded 3 February 2026 · filed 5 February 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 48 January 2026Stock option (right to buy) · traded 6 January 2026 · filed 8 January 2026
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 48 January 2026Stock option (right to buy) · traded 6 January 2026 · filed 8 January 2026
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- gave away 5,287 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 17 November 2025 · filed 3 December 2025
- acquired or disposed of, other 5,287 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 17 November 2025 · filed 3 December 2025
- ▼ sold on the open market 4,500 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 25 November 2025 · filed 3 December 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 December 2025Stock option (right to buy) · traded 2 December 2025 · filed 3 December 2025
- was granted 224 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- was granted 224 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- gave away 787 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- acquired or disposed of, other 787 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 19,360 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 640 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 4,500 shares of Corcept TherapeuticsSEC Form 426 November 2025Common Stock · traded 25 November 2025 · filed 26 November 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 47 November 2025Stock option (right to buy) · traded 5 November 2025 · filed 7 November 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 6,536 shares of Corcept TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 13,164 shares of Corcept TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 300 shares of Corcept TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 49 October 2025Stock option (right to buy) · traded 7 October 2025 · filed 9 October 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 49 October 2025Common Stock · traded 7 October 2025 · filed 9 October 2025
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 49 October 2025Common Stock · traded 7 October 2025 · filed 9 October 2025
- gave away 200 shares of Corcept TherapeuticsSEC Form 423 September 2025Common Stock · traded 19 September 2025 · filed 23 September 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 September 2025Stock option (right to buy) · traded 2 September 2025 · filed 4 September 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- ▼ sold on the open market 15,594 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- ▼ sold on the open market 4,406 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 35,007 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 August 2025Stock option (right to buy) · traded 8 August 2025 · filed 12 August 2025
- exercised options over 35,007 shares of Corcept TherapeuticsSEC Form 412 August 2025Common Stock · traded 8 August 2025 · filed 12 August 2025
- ▼ sold on the open market 35,007 shares of Corcept TherapeuticsSEC Form 412 August 2025Common Stock · traded 8 August 2025 · filed 12 August 2025
- exercised options over 14 shares of Corcept Therapeutics (a derivative holding)SEC Form 47 August 2025Stock option (right to buy) · traded 5 August 2025 · filed 7 August 2025
- exercised options over 14 shares of Corcept TherapeuticsSEC Form 47 August 2025Common Stock · traded 5 August 2025 · filed 7 August 2025
- ▼ sold on the open market 14 shares of Corcept TherapeuticsSEC Form 47 August 2025Common Stock · traded 5 August 2025 · filed 7 August 2025
- exercised options over 4,379 shares of Corcept Therapeutics (a derivative holding)SEC Form 421 July 2025Stock option (right to buy) · traded 17 July 2025 · filed 21 July 2025
- exercised options over 500 shares of Corcept Therapeutics (a derivative holding)SEC Form 421 July 2025Stock option (right to buy) · traded 18 July 2025 · filed 21 July 2025
- exercised options over 4,379 shares of Corcept TherapeuticsSEC Form 421 July 2025Common Stock · traded 17 July 2025 · filed 21 July 2025
- ▼ sold on the open market 4,379 shares of Corcept TherapeuticsSEC Form 421 July 2025Common Stock · traded 17 July 2025 · filed 21 July 2025
- exercised options over 500 shares of Corcept TherapeuticsSEC Form 421 July 2025Common Stock · traded 18 July 2025 · filed 21 July 2025
- ▼ sold on the open market 500 shares of Corcept TherapeuticsSEC Form 421 July 2025Common Stock · traded 18 July 2025 · filed 21 July 2025
- exercised options over 100 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 July 2025Stock option (right to buy) · traded 1 July 2025 · filed 3 July 2025
- exercised options over 100 shares of Corcept TherapeuticsSEC Form 43 July 2025Common Stock · traded 1 July 2025 · filed 3 July 2025
- ▼ sold on the open market 100 shares of Corcept TherapeuticsSEC Form 43 July 2025Common Stock · traded 1 July 2025 · filed 3 July 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 June 2025Stock option (right to buy) · traded 10 June 2025 · filed 12 June 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 412 June 2025Common Stock · traded 10 June 2025 · filed 12 June 2025
- ▼ sold on the open market 16,918 shares of Corcept TherapeuticsSEC Form 412 June 2025Common Stock · traded 10 June 2025 · filed 12 June 2025
- ▼ sold on the open market 3,082 shares of Corcept TherapeuticsSEC Form 412 June 2025Common Stock · traded 10 June 2025 · filed 12 June 2025
- exercised options over 32,262 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 May 2025Stock option (right to buy) · traded 16 May 2025 · filed 20 May 2025
- exercised options over 32,262 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▼ sold on the open market 32,262 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- exercised options over 7,060 shares of Corcept Therapeutics (a derivative holding)SEC Form 48 May 2025Stock option (right to buy) · traded 6 May 2025 · filed 8 May 2025
- exercised options over 7,060 shares of Corcept TherapeuticsSEC Form 48 May 2025Common Stock · traded 6 May 2025 · filed 8 May 2025
- ▼ sold on the open market 7,060 shares of Corcept TherapeuticsSEC Form 48 May 2025Common Stock · traded 6 May 2025 · filed 8 May 2025
- exercised options over 678 shares of Corcept Therapeutics (a derivative holding)SEC Form 42 April 2025Stock option (right to buy) · traded 1 April 2025 · filed 2 April 2025
- exercised options over 678 shares of Corcept TherapeuticsSEC Form 42 April 2025Common Stock · traded 1 April 2025 · filed 2 April 2025
- ▼ sold on the open market 678 shares of Corcept TherapeuticsSEC Form 42 April 2025Common Stock · traded 1 April 2025 · filed 2 April 2025
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 March 2025Stock option (right to buy) · traded 28 February 2025 · filed 4 March 2025
- exercised options over 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 March 2025Stock option (right to buy) · traded 4 March 2025 · filed 4 March 2025
- exercised options over 20,000 shares of Corcept TherapeuticsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- had shares withheld for tax on 309 shares of Corcept TherapeuticsSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- exercised options over 6,606 shares of Corcept Therapeutics (a derivative holding)SEC Form 45 November 2024Stock option (right to buy) · traded 1 November 2024 · filed 5 November 2024
- exercised options over 3,394 shares of Corcept Therapeutics (a derivative holding)SEC Form 45 November 2024Stock option (right to buy) · traded 4 November 2024 · filed 5 November 2024
- exercised options over 6,606 shares of Corcept TherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- ▼ sold on the open market 6,606 shares of Corcept TherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- exercised options over 3,394 shares of Corcept TherapeuticsSEC Form 45 November 2024Common Stock · traded 4 November 2024 · filed 5 November 2024
- ▼ sold on the open market 3,394 shares of Corcept TherapeuticsSEC Form 45 November 2024Common Stock · traded 4 November 2024 · filed 5 November 2024
- exercised options over 10,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 October 2024Stock option (right to buy) · traded 1 October 2024 · filed 3 October 2024
- exercised options over 10,000 shares of Corcept TherapeuticsSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.